Exosome Diagnostics
Bolade Olambiwonnu is an experienced sales professional with a strong background in the healthcare and diagnostics industry. Currently serving as an Account Executive at Exosome Diagnostics since August 2022, Bolade has previously held key positions, including Sr. Account Manager-Preventive at Ambry Genetics and Clinical Sales Manager at QIAGEN. Additional experience includes roles as Account Manager at Quest Diagnostics, Diabetes Care Specialist at Novo Nordisk A/S, and Pharmaceutical Sales Specialist at both Astellas Pharma and Pharmacia & Upjohn. Bolade's educational credentials include a Bachelor of Arts in Political Science and Business from UCLA.
This person is not in the org chart
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.